AnaptysBio has a PEG Value of $39.32. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 157.14% in the next year. Among companies with a PEG Value above the current stock price, AnaptysBio is ranked 226.
|10 Day Gain
AnaptysBio rank is 1443
|90 Day Loss
AnaptysBio rank is 199
|Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, AnaptysBio is ranked 204.
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, AnaptysBio is ranked 473.
AnaptysBio has a high Put/Call ratio of 0.55 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, AnaptysBio is ranked 567.
AnaptysBio has a high Put/Call ratio of 0.83 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, AnaptysBio is ranked 976.